Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat in Pediatric PFIC
NCT03353454Phase 3Withdrawn
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Oct 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of maralixibat in progressive familial intrahepatic cholestasis (PFIC), sponsored by Mirum Pharmaceuticals, Inc.. Planned start Oct 2018; status: withdrawn.
02
Drugs
maralixibat
03
Conditions
progressive familial intrahepatic cholestasis (PFIC)
Beyond the preview
Go deeper on NCT03353454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353454.